Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I, Jauhiainen S, Cashion L, Gruchala M, Närvänen O, Taipale P, Kauppinen RA, Rubanyi GM, Ylä-Herttuala S. Rissanen TT, et al. Among authors: markkanen je. FASEB J. 2003 Jan;17(1):100-2. doi: 10.1096/fj.02-0377fje. Epub 2002 Nov 15. FASEB J. 2003. PMID: 12475908
Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivelä A, Hedman A, Hedman M, Heikura T, Ordén MR, Stacker SA, Achen MG, Hartikainen J, Ylä-Herttuala S. Rutanen J, et al. Among authors: markkanen je. Circulation. 2004 Mar 2;109(8):1029-35. doi: 10.1161/01.CIR.0000115519.03688.A2. Epub 2004 Feb 16. Circulation. 2004. PMID: 14967735
Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén MR, Kholová I, de Goede A, Heikura T, Gröhn OH, Ylä-Herttuala S. Rissanen TT, et al. Among authors: markkanen je. Circulation. 2005 Dec 20;112(25):3937-46. doi: 10.1161/CIRCULATIONAHA.105.543124. Epub 2005 Dec 12. Circulation. 2005. PMID: 16344386
Gene therapy for restenosis: current status.
Rutanen J, Markkanen J, Ylä-Herttuala S. Rutanen J, et al. Drugs. 2002;62(11):1575-85. doi: 10.2165/00003495-200262110-00001. Drugs. 2002. PMID: 12109921 Review.
15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression.
Viita H, Markkanen J, Eriksson E, Nurminen M, Kinnunen K, Babu M, Heikura T, Turpeinen S, Laidinen S, Takalo T, Ylä-Herttuala S. Viita H, et al. Circ Res. 2008 Feb 1;102(2):177-84. doi: 10.1161/CIRCRESAHA.107.155556. Epub 2007 Nov 8. Circ Res. 2008. PMID: 17991885
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Niemi M, Leppänen P, Turunen MP, Markkanen JE, Arve K, Alhava E, Kauppinen RA, Ylä-Herttuala S. Rissanen TT, et al. Among authors: markkanen je. Am J Pathol. 2002 Apr;160(4):1393-403. doi: 10.1016/S0002-9440(10)62566-7. Am J Pathol. 2002. PMID: 11943724 Free PMC article.
14 results